The Dime

How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson

May 16, 2024

53:43

Synthesis, a process that may sound complex, is actually quite common in our daily lives. From the production of everyday items like Advil, organic milk, citric acid, to the creation of vitamins A and D, and multivitamins, synthesis is a key player.

Why does this realization often provoke a negative reaction?

Perhaps it's because there's a desire for clean, safe, and consistent natural products, especially when they originate from plants.

Surprisingly, synthesis enhances our ability to deliver such products.

This week, we're joined by Shane Johnson to delve into the following topics:

How minors are manufactured, synthetic vs. biosynthetic
Upcoming Minors to keep an eye on
Novel APIs & Analogs

About Dr. Shane Johnson

Dr. Shane Johnson’s career has focused principally on offering strategic business advisory services to companies in the biotechnology and healthcare sectors. His work has included guiding regulatory strategy, product portfolio assessment and valuations, and product development and launch strategies for companies including Biogen Idec, Amgen, and Genentech. Shane was a Principal at Hamilton BioVentures (a Life Science venture capital firm), an Engagement Manager at L.E.K. Consulting (an international strategy consulting firm), and held operational roles in several early stage companies. For the past 4 years, Shane’s work has been focused on the cannabis and cannabinoid science space, and he has developed a strong working knowledge of clinical opportunities in the sector. He is currently on the Board of Directors of several cannabis-related companies, and is a co-founder of one of Nevada’s leading cultivators and producers of premium cannabis products including a patented lozenge. Shane holds a B.A. in Studio Art and a B.S. in Neuroscience (with honors) from Brown University, an M.D. from the Stanford University School of Medicine, and is a Fulbright Scholar.

Guest Links